Navigation Links
MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
Date:12/19/2012

.1 million in the comparable quarter last year. Sales and marketing expenses were $2.5 million compared to $1.8 million in the fourth quarter of fiscal year 2011. Increases included GPO fees; personnel/consulting and related meeting, travel and convention costs introducing rebranded products, as well as separation costs totaling $90,000 for terminated sales and marketing management positions. Research and development costs were $791,000 compared to $852,000 in last year's fourth quarter.

For fiscal year 2012, the Company reported total revenues of $27.2 million compared to $27.0 million in fiscal year 2011. Income from discontinued operations was $1.1 million, reflecting a gain of $816,000 attributable to the sale of the Company's New Leaf assets to Life Time Fitness, Inc. on August 28, 2012, compared to a loss of $712,000 in fiscal 2011 (see "Discontinued Operations" below). The Company reported a net loss of $1,000, or $(0.00) per fully diluted share, compared to a net loss of $152,000, or $(0.04) per diluted share in fiscal year 2011.

Gregg O. Lehman,Ph.D., president and chief executive officer of MGC Diagnostics, said, "As we enter fiscal year 2013, the former Angeion Corporation has completely transformed into MGC Diagnostics, a highly-focused global medical technology company specializing in cardio/respiratory health solutions. We have reconfigured and strengthened the executive management team and now have the appropriate skill sets to consistently grow the company. We have streamlined the sales and marketing management team to enhance efficiencies that will drive sales. We have successfully rebranded our products and corporate identity by leveraging the strength of our highly respected MedGraphics brand and we concluded the sale of our New Leaf operations to Life Time Fitness, Inc.

"From an operating standpoint, we have taken a major step in stabilizing, and bringing a level of predictability to our revenue stream by having expanded our
'/>"/>

SOURCE MGC Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  Savant HWP, ... confirmed the initiation of human safety testing of ... addiction. A single dose of 18-MC, administered as ... conducted by Savant,s South American partner, was well ... Savant HWP plans to develop 18-MC as a ...
(Date:9/23/2014)... FRANCISCO , Sept. 23, 2014 Today, ... (ORS), announced the formation of the DripDrop Foundation, ... to preventable dehydration worldwide. Utilizing scientific advancements in ... introduce solutions to reduce dehydration and healthcare costs ... relief missions. "DripDrop has been ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... new additions to its Scientific Advisory Board.  The new ... Anthony Davies , PhD. Dr. Acker is ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3DripDrop Forms Foundation To Scale Relief Efforts 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... Nektar,Therapeutics (Nasdaq: NKTR ) today ... study,for NKTR-118 (PEG-naloxol), an oral treatment being ... clinical manifestations of,opioid-induced bowel dysfunction (OBD). The ... safety and tolerability,of NKTR-118 in patients experiencing ...
... Nastech Pharmaceutical,Company Inc. (Nasdaq: NSTK ) announced ... trial of PYY3-36 Nasal Spray to treat obesity. ... sites in the United States,for a six-month, randomized, ... evaluate three different doses of PYY3-36 Nasal Spray,compared ...
Cached Medicine Technology:Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 2Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 3Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 4Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 5Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 2Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 3
(Date:9/23/2014)... 2014 The "area under the curve of oxygen ... approach to monitoring blood oxygen levels during procedures using ... & Analgesia . , The AUC Desat provides ... lowbut also on the depth, duration, and rate of ... Paul Niklewski, PhD, of University of Cincinnati and colleagues ...
(Date:9/23/2014)... the physical and mental health of girls and ... by researchers from the Institute for Reproductive Health ... effective strategies to change inequitable and harmful social ... Inequitable gender norms are not only related to ... as multiple sexual partners, smoking and alcohol abuse ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 The ... is now offering complimentary oral sedation with treatment for ... of Americans suffer from dental anxiety or dental phobia. ... patients; they can also keep patients from seeking desperately ... phobia in Westlake Village and surrounding areas now have ...
(Date:9/23/2014)... On September 23, 2014, My Positive Perspective founder Jason Deierlein ... the founder of Traveler of Charleston magazine and answered some ... At the start of the interview, Deierlein asked Simmons, “How ... replied by saying, “I had worked for the yellow pages ... and decided to start my own magazine thinking I could ...
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
Breaking Medicine News(10 mins):Health News:New measure provides more data on oxygen levels during sedation 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 3Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2
... ... for small groups and business insurance premiums. Now, they are getting some answers and are ... , ... 3, 2009 -- The health care reform bills in being considered by the House, which ...
... , CHICAGO, July 2 Recent news reports have ... physicians meet high standards in their chosen area of ... (ABMS), which coordinates and assists its 24 Member Boards ... professional standards for the evaluation and certification of physician ...
... Dr Daniel Goldberg, a leading New Jersey ophthalmologist is ... 5% Betadine irrigation for treatment of acute EKC -- a ... with the potential for long term visual impairment due to ... invited to register to participate in the Betadine for EKC ...
... can help reduce threat, expert says , THURSDAY, ... threat to certain species of wildlife, which need to ... is one of the leading health concerns for humans, ... But we now understand that cancer can kill wild ...
... hepatitis B virus (HBV) are associated with the development of ... infections are at increased risk of the disease, according to ... Cancer Institute , published online July 2. HBV infection ... common form of liver cancer. Previous studies have looked at ...
... 2 American Scientific Resources, Inc. (Pink Sheets: ASFX), ... McWilliams, will be dedicating herself full-time to the position ... for Next One Interactive. , , Ms. ... Chief Financial Officer. She possesses in-depth, practical knowledge ...
Cached Medicine News:Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Cancer Endangers Some Wildlife Species 2Health News:American Scientific Resources Announces Acting CFO Transition to Full-Time 2
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
... Liquichek Lipids Control is ... product that provides the ... analyte levels for lipids ... C-Reactive Protein in levels ...
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: